Furthermore, NFKBIZ has been shown to be downregulated in bladder cancer and to affect the PI3K/AKT/mTOR pathway to inhibit proliferation (Xu et al. 2021). The gene discussed is MTOR; the disease is urinary bladder carcinoma.